Anthropic is redeploying Claude Fable 5 after a sudden 18-day US export control order triggered by an Amazon cybersecurity bypass report was lifted.
The CodeBreaK 100 study from Amgen Inc. is a Phase 1/2 trial testing sotorasib in advanced solid tumors with a KRAS p.G12C mutation. It aims to find a safe dose, check how the drug behaves in the body ...
Frontier model launches are starting to look less like ordinary product releases and more like negotiated deployments shaped by U.S. national security review.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results